Our mission is to deliver predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life.
San Francisco, CA
Joined September 2018
- Tweets37
- Following44
- Followers57
- Likes11
We’re announcing a new study on #dementia and medical #cannabis led by @NorthwellHealth at the 2nd Annual New York State Medical Cannabis Symposium.
prnewswire.com/news-releases…
Proud to see our own @epsteink featured in @CBTmag with an op-ed on how the cannabis industry can better serve people managing complex health conditions—and improve business outcomes. cannabisbusinesstimes.com/bu…
Cannformatics Announces Scientific Reports Publication Revealing Groundbreaking Progress in Personalizing Medical ... prn.to/3skyzHY
Thank you @drcaplan for your support.
Groundbreaking progress in personalizing medical cannabis treatment for Autism Spectrum Disorder (ASD) is on the horizon. Cannformatics is pioneering the use of biomarkers & machine learning to tailor therapies for neuro disorders. How could this change lives! #ASD #CannabisCare
Thrilled to announce the publishing of our 3rd paper in @SciReports revealing our groundbreaking discoveries from combining Cannabis-Responsive #biomarkers and #MachineLearning towards personalizing #medicalcannabis treatment for #ASD #PTSD #Alzheimers nature.com/articles/s41598-0…
".@Altmetric has tracked 19,731,023 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the TOP 5% of all research outputs EVER TRACKED by Altmetric." liebertpub.com/doi/10.1089/c…
Thank you Caroline Barry and @CannabisHnews for covering this important paper. #biotech #medicalcannabis #cbdhealth #biomarkers #metabolomics #research
Study on autism spectrum disorder (ASD) identifies cannabis-responsive biomarkers in children
@Autism estimates that one in every 100 people are on the autism spectrum with 700,000 adults and children in the UK.
Read more:
cannabishealthnews.co.uk/202… @cannformatics
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder | Cannabis and Cannabinoid Research liebertpub.com/doi/10.1089/c…
Check out our Chief Commercial Officer
@epsteink
discussing Cannabis-Responsive biomarkers on
@TheCBDEDShow1. voiceamerica.com/show/3919/t…
#medicalcannabis #autism #CBD #biotechnology #research
Great being on the @TheCBDEDShow1 on @VoiceAmVariety talking about @cannformatics #ASD Study. voiceamerica.com/episode/134…
Great @Medium post by journalist @leddder on @cannformatics discovery of Cannabis Responsive #biomarkers to measure #medicalcannabis’ impact on children with #autism. lesterbblack.medium.com/stud…
Cannformatics Discovers Tool For Objectively Measuring Medical Cannabis Benefits In Children With Autism | Benzinga benzinga.com/markets/cannabi… via @benzinga
Excited to see over 3-years of #biotechnology research and the participation of the children and their families be validated by the publishing of this paper. This is the first step in advancing precision #medicalcannabis & #CBD treatment. #autism
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with #AutismSpectrumDisorder
Read Now: ow.ly/xu5Z50H5Avt
First study to use Cannabis-Responsive #biomarkers to examine the #metabolic response in saliva of children with #ASD treated with various #medicalcannabis or #CBD products widely available in licensed California dispensaries. prn.to/33f2aGx
Cannformatics Scientific Advisor Dr. Donald Abrams comments on the the challenges clinicians and #breastcancer patients face when discussing the use of #MedicalCannabis in relieving treatment side effects. medscape.com/viewarticle/961…
We're excited to welcome medical #cannabis expert Dr. Bonni Goldstein to our esteemed Advisory Board. Dr. Goldstein will provide advise on our #clinical studies used to identify Cannabis-Responsive #biomarkers prn.to/3AFm2hr
We're excited to welcome Congressman Edward Feighan to our Advisory Board. Mr. Feighan's #canabinoid-based, #pharma and #policy making experience makes him a welcome addition to the Cannformatics team. prn.to/37DZYaO
Proud to welcome @canniatric and @wpa4a as sponsors of our #autism spectrum disorder pilot study. This is the first #IRB approved study to assess the impact of #medicalcannabis using #biomarkers found in saliva. #metabolomics #asd prn.to/30HYI2P
Cannformatics retweeted
A review on the therapeutic potential of cannabinoids (#THC, #CBD) and drugs that modulate the #endocannabinoid system for common neurodegenerative disorders, namely #Parkinsons & #Alzheimers disease.
link.springer.com/article/10…
